Summaries of health policy coverage from major news organizations
Bayer Joins Fight Against AIDS
Bayer A.G., Germany's
largest pharmaceutical manufacturer, announced yesterday plans to
concentrate research in 13 medical fields, including HIV/AIDS, in
an effort to "increase sales and profits," Bloomberg
News/New York Times reports. The company, best known for
its aspirin, did not disclose how much it will invest in AIDS
research (Bloomberg News/New York Times, 11/22).
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Thank you for your interest in supporting Kaiser Health News (KHN), the nation’s leading nonprofit newsroom focused on health and health policy. We distribute our journalism for free and without advertising through media partners of all sizes and in communities large and small. We appreciate all forms of engagement from our readers and listeners, and welcome your support.
KHN is an editorially independent program of KFF (Kaiser Family Foundation). You can support KHN by making a contribution to KFF, a non-profit charitable organization that is not associated with Kaiser Permanente.
Click the button below to go to KFF’s donation page which will provide more information and FAQs. Thank you!